Ask Warren

Kolon TissueGene

950160 · KOSDAQ · ₩950160 · 코오롱티슈진

₩13,920▼ ₩380 (2.66%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩552,123₩962,649₩585,091₩1.2M₩940,892₩886,776₩545,235₩1.6M
Cost of sales₩478,947₩847,353₩509,555₩1.1M₩808,849₩773,832₩457,438₩1.4M
Gross profit₩73,176₩115,296₩75,536₩161,291₩132,043₩112,944₩87,797₩153,569
Operating income−₩4.8M−₩3.7M−₩5.6M−₩2.5M−₩3.9M−₩3.7M−₩4.7M−₩4.3M
Net income₩102M−₩68M−₩131M₩36M−₩36M−₩4M−₩20M−₩422,487
Net income to shareholders₩102M−₩68M−₩131M₩36M−₩36M−₩4M−₩20M−₩422,487

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩333M₩337M₩295M₩290M₩205M₩211M₩151M₩146M
Current assets₩66M₩84M₩60M₩92M₩24M₩42M₩5M₩24M
Cash and equivalents₩44M₩63M₩47M₩72M₩10M₩36M₩546,173₩22M
Total liabilities₩200M₩255M₩251M₩159M₩120M₩86M₩52M₩33M
Current liabilities₩198M₩252M₩248M₩156M₩116M₩82M₩48M₩30M
Borrowings₩37M₩39M₩52M₩50M₩29M₩20M₩7.4M₩8.3M
Total equity₩132M₩82M₩45M₩131M₩85M₩125M₩99M₩113M
Shareholders' equity₩132M₩82M₩45M₩131M₩85M₩125M₩99M₩113M

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩855,617−₩4M−₩3.5M−₩3.7M₩3.1M−₩13M−₩3.3M−₩3.6M
Capital spending₩54,290₩19,862₩57,687₩359,962₩414,943₩8,477₩69,275₩17,407
Free cash flow−₩909,907−₩4.1M−₩3.5M−₩4.1M₩2.7M−₩13M−₩3.4M−₩3.7M

Consolidated where available. Amounts in won.

Also known as: Kolon TissueGene / 코오롱티슈진 / 950160 / KRX:950160

Source: KRX statistical information